Author:
Wang Yi-Wei,Wang Liang,Yuan Sheng-Jie,Zhang Yuan,Zhang Xin,Zhou Le-Ting
Abstract
BackgroundPostoperative cognitive dysfunction (POCD) is a common complication characterized by a significant cognitive decline. Increasing evidence suggests an association between the pathogenesis of POCD and Alzheimer’s disease (AD). However, a comprehensive understanding of their relationships is still lacking.MethodsFirst, related databases were obtained from GEO, ArrayExpress, CNGB, and DDBJ repositories. De novo analysis was performed on the raw data using a uniform bioinformatics workflow. Then, macro- and micro-level comparisons were conducted between the transcriptomic changes associated with AD and POCD. Lastly, POCD was induced in male C57BL/6j mice and the hippocampal expression levels of mRNAs of interest were verified by PCR and compared to those in AD congenic models.ResultsThere was a very weak correlation in the fold-changes in protein-coding transcripts between AD and POCD. Overall pathway-level comparison suggested that AD and POCD are two disease entities. Consistently, in the classical AD pathway, the mitochondrial complex and tubulin mRNAs were downregulated in both the POCD hippocampus and cortex. POCD and AD hippocampi might share the same pathways, such as tryptophan metabolism, but undergo different pathological changes in phagosome and transferrin endocytosis pathways. The core cluster in the hippocampal network was mainly enriched in mitosis-related pathways. The hippocampal expression levels of genes of interest detected by PCR showed good consistency with those generated by high throughput platforms.ConclusionPOCD and AD are associated with different transcriptomic changes despite their similar clinical manifestations. This study provides a valuable resource for identifying biomarkers and therapeutic targets for POCD.
Funder
National Natural Science Foundation of China
Subject
Cognitive Neuroscience,Aging
Reference46 articles.
1. Surgery, neuroinflammation and cognitive impairment.;Alam;EBioMedicine,2018
2. Postoperative cognitive dysfunction, Alzheimer’s disease, and anesthesia.;Arora;Int. J. Neurosci.,2014
3. The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: implications in the Therapy of Alzheimer’s Disease.;Banerjee;J. Alzheimers Dis.,2016
4. Genetic insights in Alzheimer’s disease.;Bettens;Lancet Neurol.,2013
5. Postoperative cognitive dysfunction: toward the Alzheimer’s disease pathomechanism hypothesis.;Bilotta;J. Alzheimers Dis.,2010
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献